Here's a look at some of the top legal news stories for medical device companies this week: Baxter drops FloSeal case against J&J; Feds: We got $119m in fraud penalties from medtech companies last year; Insurer, DJO Global settle pain pump suit
, Boston Scientific
, CareFusion Corp.
, Dept. of Health & Human Services (HHS)
, Dept. of Justice (DOJ)
, DJO Global
, Ethicon Inc.
, Ironshore Specialty Insurance
, Johnson & Johnson
, Omni Surgical/Spine360
, Smith & Nephew
, Abbott Laboratories
, Genzyme Corp.
The U.S. Health & Human Services Dept. and the Justice Dept. say they collected some $119 million in healthcare fraud penalties from medical device companies during fiscal 2014.
Smith & Nephew CEO Olivier Bohuon reportedly tells employees that he's not in the running for the top job at French drug maker Sanofi.
Smith & Nephew CEO Olivier Bohuon is said to be a leading candidate for the top job at French drugmaker Sanofi, which axed its CEO last week without a replacement.
Medtronic and Sanofi embark on a global alliance to combine human and financial resources in the interest of new products and services for patients with diabetes.
Sanofi subsidiary Genzyme agrees to pay $22.3 million to settle accusations that its sales rep encouraged off-label use of the Seprafilm surgical product.
Massachusetts-based Genzyme Corp., a subsidiary of Sanofi (NYSE:SNY), agreed to pay $22.3 million to settle a whistleblower lawsuit accusing the company of off-label marketing of its Seprafilm surgical product.
A pair of brokers plead guilty to charges of insider trading in Stryker Corp. stock ahead of its 2011 acquisition of Orthovita.
A pair of brokers pleaded guilty to federal insider trading charges yesterday, admitting that they used tips from a former Stryker (NYSE:SYK) marketing executive to make illicit trades ahead of the medical device company's 2011 acquisition of Orthovita.